Abstract:Background Atrial fibrillation (AF), as the most burdensome cardiac arrhythmia, could lead to the significant mortality and morbidity. Atrial fibrosis is a well-recognized pathophysiological factor of the development and progression of AF, which also hampers its treatment. However, the underlying mechanisms of this intricate process remain largely unknown. Purpose This study sought to reveal the cellular composition of AF substrate and investigate the vital contributors to atrial structural remodeling. Methods Left atrial appendages from three patients with AF undergoing surgical ablation and three individuals with sinus rhythm undergoing heart transplantation were subjected to 10X single-cell RNA sequencing (scRNA-seq). Another five public scRNA-seq or snRNA-seq datasets of potentially remodeled right or left appendages were retrieved across three publications. The vital contributors of atrial structural remodeling and their characteristics were identified by intercellular communication analysis and trajectory inference. Transverse aortic constriction (TAC) was used to induce atrial remodeling in Cdh5-CreERT2;RFP mice, followed by scRNA-seq of endothelial cells (ECs). Human primary atrial ECs and fibroblasts were isolated for cell-cell interaction experiments. ECs-specific mouse models of Transforming growth factor beta 1 (TGFB1) (knockout and overexpression) were generated. Electrophysiological and histology analyses were performed to determine the consequences of ECs-derived TGFB1 gain and loss of function in the atrium. Results The comprehensive analysis of different scRNA-seq datasets revealed that ECs played an important regulatory role in the homeostasis of atrial substrate and displayed remarkable mesenchymal activation during atrial remodeling, which was further confirmed by TAC mice. Immunofluorescence staining and high-content screening suggested that the complete transition from ECs to mesenchymal cells slightly contributed to atrial remodeling. However, TGFB1 secreted from mesenchymal activated ECs significantly promoted activation, proliferation, and collagen secretion of fibroblasts. We discovered that overexpression of TGFB1 in ECs of mice significantly increased atrial fibrosis, and thus prolonging AF duration. Besides, knockout of TGFB1 in ECs of mice underwent TAC significantly attenuated the atrial fibrosis and decreased the rate of AF. Conclusion Our work demonstrates that mesenchymal ECs-derived Tgfb1 plays an important role in atrial remodeling by regulating the fibroblast function. EC-specific interventions were suggested to facilitate the development of novel strategies for mitigating AF substrate remodeling.

Possible Involvement Of Tgf-Beta/Periostin In Fibrosis Of Right Atrial Appendages In Patients With Atrial Fibrillation

Possible involvement of fibrocytes in atrial fibrosis in patients with chronic atrial fibrillation.

Expression of BRD4 in patients with nonvalvular atrial fibrillation and its role in postoperative recurrence and the development of atrial fibrosis

Ang II Enhances Atrial Fibroblast Autophagy and Promotes Atrial Remodeling Through the AT1-ERK-mTOR Signaling Pathway

Activation of Extracellular-Signal Regulated Kinase and Protein Phosphatases in Human Atria During Atrial Fibrillation

Premature Senescence of Cardiac Fibroblasts and Atrial Fibrosis in Patients with Atrial Fibrillation

Study of the atrial fibrosis and the expression of PDGF receptor-β during atrial fibrillation

The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation

Research of left-atrial fibrosis of atrial fibrillation patient and its effect to post-operative rhythm of radiofrequency ablation treatment

Accumulated β-catenin is associated with human atrial fibrosis and atrial fibrillation

E0356 the Research on Calcium Homeostasis Expression and Gene Transcription of Atrial Myocytes in Patients with Atrial Fibrillation

Integrating single-cell sequencing and genetic lineage tracing reveals endothelial plasticity during atrial remodeling

LIM Kinase 1 Acts As a Profibrotic Mediator in Permanent Atrial Fibrillation Patients with Valvular Heart Disease

Sirt1 Inhibits Atrial Fibrosis by Downregulating the Expression of the Transforming Growth Factor-β1/Smad Pathway

Does the expression of transforming growth factor β-1: affect the outcome of the radiofrequency modified maze procedure in patients with rheumatic atrial fibrillation?

The relationship between atrial fibrillation caused atrial remodeling and expression of related cytokines

The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis

[Changes of Interleukin-1Beta and Tumor Necrosis Factor-Alpha of Right Atrial Appendages in Patients with Rheumatic Valvular Disease Complicated with Chronic Atrial Fibrillation].

Involvement of plasminogen activator inhibitor-1 and its related molecules in atrial fibrosis in patients with atrial fibrillation

Expression of Matrix Metalloproteinase and Cytokines During Atrial Fibrillation Investigation

Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation